Neuroimmunology Reports最新文献

筛选
英文 中文
Brazilian perspectives on neurosarcoidosis broad spectrum 巴西人对神经结节病广谱的看法
Neuroimmunology Reports Pub Date : 2025-01-01 DOI: 10.1016/j.nerep.2025.100249
Carolina B. Moura , Flávia Aguiar Machado , Johnatan Felipe Ferreira da Conceição , Isadora Gomes Mesquita , Rafael Santos Correia , Rodrigo Cutrim Gaudio , Melina da Silva Bernardes , Lucas F B Horta , Caroline Bittar-Braune
{"title":"Brazilian perspectives on neurosarcoidosis broad spectrum","authors":"Carolina B. Moura ,&nbsp;Flávia Aguiar Machado ,&nbsp;Johnatan Felipe Ferreira da Conceição ,&nbsp;Isadora Gomes Mesquita ,&nbsp;Rafael Santos Correia ,&nbsp;Rodrigo Cutrim Gaudio ,&nbsp;Melina da Silva Bernardes ,&nbsp;Lucas F B Horta ,&nbsp;Caroline Bittar-Braune","doi":"10.1016/j.nerep.2025.100249","DOIUrl":"10.1016/j.nerep.2025.100249","url":null,"abstract":"<div><h3>Background</h3><div>Neurosarcoidosis (NS) is a rare form of sarcoidosis, characterized by a wide range of neurological presentations due to granulomatous inflammation affecting different areas of the nervous system. The prevalence of NS in Brazil is not well-documented, suggesting a risk of underdiagnosis in this region.</div></div><div><h3>Case Series</h3><div>This study examines a series of five patients from Brazil with biopsy-confirmed systemic sarcoidosis and probable NS. Neurological manifestations varied widely, including longitudinally extensive myelitis, myopathy, cerebellar involvement, orbital apex syndrome, and multiple cranial neuropathies. NS was the initial presentation of sarcoidosis in most cases. Diagnoses were confirmed through a detailed assessment of clinical, radiological, laboratory, and pathological findings, following established NS diagnostic criteria. Each patient underwent MRI, cerebrospinal fluid analysis, and systemic evaluations, with systemic sarcoidosis confirmed by biopsy. Treatment primarily involved corticosteroids, with some patients requiring additional immunosuppressive therapy, resulting in favorable outcomes.</div></div><div><h3>Conclusions</h3><div>This case series highlights the diagnostic challenges of NS, particularly in Brazil, where awareness may be limited. Neurologists should consider NS in cases of unexplained neurological symptoms accompanied by systemic signs. Prompt diagnosis and treatment are essential to improve patient outcomes in this potentially debilitating condition.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"7 ","pages":"Article 100249"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143171847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmune demyelinating central nervous system disease in young male with persistently positive fluorescent treponemal antibody absorption test: A case report 自身免疫性脱髓鞘中枢神经系统疾病的年轻男性持续阳性荧光螺旋体抗体吸收试验:1例报告
Neuroimmunology Reports Pub Date : 2024-12-01 DOI: 10.1016/j.nerep.2024.100233
Mario B Prado , Karen Joy Adiao
{"title":"Autoimmune demyelinating central nervous system disease in young male with persistently positive fluorescent treponemal antibody absorption test: A case report","authors":"Mario B Prado ,&nbsp;Karen Joy Adiao","doi":"10.1016/j.nerep.2024.100233","DOIUrl":"10.1016/j.nerep.2024.100233","url":null,"abstract":"<div><div>For NMOSD and MOGAD, onset and relapses are often preceded by non-specific infections, but up until now no known microorganism has been identified to be strongly associated with these conditions. Syphilis as inciting event for NMOSD or MOGAD has only been reported once (Wilcox et al., 2008). This case report examines whether syphilis triggers autoimmune CNS condition or autoimmune CNS disease may cause false positive confirmatory treponemal test. The patient is a 30-year-old who came in with 8-month history of sudden onset spasticity and ataxia of bilateral lower extremities and blindness, confirmed to be transverse myelitis via imaging and optic neuritis by optic coherence tomography respectively. Anti-AQ4 and anti-MOG were negative, however, the patient repeatedly tested positive in FTA-ABS. We suspect that through molecular mimicry and bystander activation, there is a possibility that syphilis may have incited the onset and relapse of his autoimmune CNS demyelinating condition.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100233"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142744787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guillain-Barré syndrome associated with COVID-19 infection: A case series 与COVID-19感染相关的格林-巴利综合征:病例系列
Neuroimmunology Reports Pub Date : 2024-11-13 DOI: 10.1016/j.nerep.2024.100231
João Hugo Abdalla Santos , Ligia Fernandes Abdalla , Luana Catarina Marinho Serruya , Wolfgang Lucas Silva de Paula , Felipe Gomes Naveca
{"title":"Guillain-Barré syndrome associated with COVID-19 infection: A case series","authors":"João Hugo Abdalla Santos ,&nbsp;Ligia Fernandes Abdalla ,&nbsp;Luana Catarina Marinho Serruya ,&nbsp;Wolfgang Lucas Silva de Paula ,&nbsp;Felipe Gomes Naveca","doi":"10.1016/j.nerep.2024.100231","DOIUrl":"10.1016/j.nerep.2024.100231","url":null,"abstract":"<div><div>This study reports three cases of Guillain-Barré Syndrome (GBS) associated with SARS-CoV-2 infection at a tertiary hospital in Manaus, Brazil. The patients presented with atypical epidemiological profiles and manifestations, deviating from the classic presentation of the syndrome. In the first case, a 20-year-old patient exhibited lower limb paresthesias and respiratory symptoms. The second case involved a 29-year-old patient with a range of symptoms, including asthenia, diarrhea, and vertigo. The third case, a 51-year-old patient with a history of COVID-19, initially manifested dysautonomia and later developed weakness in the lower limbs. The administration of human immunoglobulin led to significant improvements in all cases within a period of one month to six weeks. Despite these outcomes, the underlying mechanisms varied between cases, highlighting the complexity of this association and emphasizing the need for further research to better understand the factors involved in the link between GBS and COVID-19.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100231"},"PeriodicalIF":0.0,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142698245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain leptomeningeal enhancement and cranial nerve enhancement in a pediatric-onset multiple sclerosis patient during fingolimod rebound: A case report 一名儿科多发性硬化症患者在芬戈莫德反弹期间出现脑膜强化和颅神经强化:病例报告
Neuroimmunology Reports Pub Date : 2024-11-01 DOI: 10.1016/j.nerep.2024.100232
Nikoloz Karazanashvili , Monica M. Diaz , Jorge L. Almodovar , Bushra Javed , Stephanie Iyer , Irena Dujmovic Basuroski
{"title":"Brain leptomeningeal enhancement and cranial nerve enhancement in a pediatric-onset multiple sclerosis patient during fingolimod rebound: A case report","authors":"Nikoloz Karazanashvili ,&nbsp;Monica M. Diaz ,&nbsp;Jorge L. Almodovar ,&nbsp;Bushra Javed ,&nbsp;Stephanie Iyer ,&nbsp;Irena Dujmovic Basuroski","doi":"10.1016/j.nerep.2024.100232","DOIUrl":"10.1016/j.nerep.2024.100232","url":null,"abstract":"<div><div>We report a case of leptomeningeal and trigeminal nerve enhancement in an African American male patient with pediatric onset (age 17) relapsing-remitting multiple sclerosis (MS) during fingolimod rebound. The patient was clinically and radiologically stable while on fingolimod for 3.5 years, but developed disease rebound following fingolimod self-discontinuation. During this episode, several new T2/fluid-attenuated inversion recovery (FLAIR) lesions, enlarging T2/FLAIR lesions and contrast-enhancing lesions in the brain (supratentorial, cerebellum, brainstem) and spinal cord, enhancement of both trigeminal nerves and mild leptomeningeal enhancement (LME) around the brainstem were seen on brain magnetic resonance imaging (MRI). LME or cranial nerve enhancement (CNE) were not present on prior MRI studies, or on MRI studies performed after the patient recovered from fingolimod rebound. LME and CNE in MS may occur during rebound MS activity following fingolimod discontinuation as a transient phenomenon.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100232"},"PeriodicalIF":0.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142593072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transiently elevated anti-CRMP-5 autoantibodies in two patients with myelitis without underlying malignancy 两名无恶性肿瘤基础的脊髓炎患者体内一过性升高的抗CRMP-5自身抗体
Neuroimmunology Reports Pub Date : 2024-10-30 DOI: 10.1016/j.nerep.2024.100229
Kennan Negrete , Zeinab Awada , Asaff Harel , Ilya Kister
{"title":"Transiently elevated anti-CRMP-5 autoantibodies in two patients with myelitis without underlying malignancy","authors":"Kennan Negrete ,&nbsp;Zeinab Awada ,&nbsp;Asaff Harel ,&nbsp;Ilya Kister","doi":"10.1016/j.nerep.2024.100229","DOIUrl":"10.1016/j.nerep.2024.100229","url":null,"abstract":"<div><h3>Introduction</h3><div>Collapsin response-mediator protein 5 (CRMP-5) is a cytoplasmic regulator of neurite outgrowth. Antibodies against CRMP-5 are associated with various neurologic diseases, including myelitis. Underlying malignancy is present in 70 – 90 % of patients with CRMP-5 autoimmunity. We present two patients with myelitis and transiently elevated anti-CRMP-5 without evidence of malignancy and discuss the relevance of the antibody in these cases.</div></div><div><h3>Case Report</h3><div>1. A 44-year-old male presented with symptoms of subacute thoracic myelitis and was found to have a persistently enhancing cord lesion on MRI. Serum anti-CRMP-5 antibody levels were initially elevated but absent on subsequent testing. Three whole-body PET scans during a three-year follow-up failed to uncover a malignancy. Neurologic condition improved on steroids. 2. A 65-year-old female presented with symptoms of a cervical myelitis followed by left facial weakness. MRI demonstrated multiple brain and spinal cord lesions as well as evidence of cranial neuritis, which persisted despite pulse steroid courses. Elevated serum anti-CRMP-5 was noted nine months after symptom onset. Malignancy workup failed to identify neoplasm and anti-CRMP-5 level subsequently seroreverted. Clinical and radiographic improvement occurred over several years of follow-up.</div></div><div><h3>Conclusion</h3><div>CRMP-5 autoantibody is a marker for paraneoplastic autoimmune neurologic syndromes. However, these two cases illustrate the uncertainty regarding its significance, as anti-CRMP-5 was only transiently elevated and not associated with an underlying malignancy. The possibilities that anti-CRMP-5 autoantibodies were an incidental or false-positive finding are discussed.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100229"},"PeriodicalIF":0.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142539516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac events in the setting of ofatumumab treatment: An association or A Co-incidence? 使用伊妥单抗治疗时的心脏事件:关联还是巧合?
Neuroimmunology Reports Pub Date : 2024-10-14 DOI: 10.1016/j.nerep.2024.100228
Hamna Khan , Michelle Maynard , Ahmed Z. Obeidat
{"title":"Cardiac events in the setting of ofatumumab treatment: An association or A Co-incidence?","authors":"Hamna Khan ,&nbsp;Michelle Maynard ,&nbsp;Ahmed Z. Obeidat","doi":"10.1016/j.nerep.2024.100228","DOIUrl":"10.1016/j.nerep.2024.100228","url":null,"abstract":"<div><h3>Background</h3><div>Despite its rarity, concerns about cardiac complications could be linked to ofatumumab in line with its cardiac risks in non-MS treatments. Here, we provide a first-time report of two instances of acute myocardial events in women under 50 temporally associated with ofatumumab for the treatment of multiple sclerosis (MS). Both patients were also on stimulant medications, suggesting that clinicians should take caution when prescribing anti-CD20 agents to patients with cardiovascular risk factors or concomitant use of stimulants.</div></div><div><h3>Discussion</h3><div>Further research is needed to confirm and quantify the association between anti-CD20 agents in use in patients with cardiovascular risk factors on concomitant use of stimulants.</div></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100228"},"PeriodicalIF":0.0,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142527059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Very late-onset neuromyelitis optica presenting with simultaneous bilateral optic neuritis and myelitis: A case report 极晚期神经脊髓炎同时伴有双侧视神经炎和脊髓炎:病例报告
Neuroimmunology Reports Pub Date : 2024-09-14 DOI: 10.1016/j.nerep.2024.100227
S Gandelman , S Parauda , C Dohle
{"title":"Very late-onset neuromyelitis optica presenting with simultaneous bilateral optic neuritis and myelitis: A case report","authors":"S Gandelman ,&nbsp;S Parauda ,&nbsp;C Dohle","doi":"10.1016/j.nerep.2024.100227","DOIUrl":"10.1016/j.nerep.2024.100227","url":null,"abstract":"<div><h3>Background</h3><p>New-onset Neuromyelitis Optica Spectrum Disorder (NMOSD) has rarely been reported in adults over age 70. We describe a severe presentation in a 77-year-old female.</p></div><div><h3>Case</h3><p>The patient presented with left arm numbness, followed by left leg numbness and bilateral optic neuritis. Neuroimaging showed a C2-T1 lesion with C4-C7 holocord enhancement, and bilateral optic nerve enhancement extending to the optic chiasm. Serum testing detected anti-aquaporin-4 antibodies. She was left with dyschromatopsia, myelopathy, and ambulatory dysfunction. She had a history notable for rheumatoid arthritis, treated with rituximab, which had been discontinued six years prior to presentation.</p></div><div><h3>Discussion</h3><p>Very-late-onset NMOSD encompasses a unique cohort of patients with significant immunogenicity despite immunosenescence. Limited data suggest diagnostic delays, severe morbidity, and decreased utilization of disease-modifying therapies.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100227"},"PeriodicalIF":0.0,"publicationDate":"2024-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000287/pdfft?md5=911d5b73fdd8fbd05a4f3ee1c3b475a6&pid=1-s2.0-S2667257X24000287-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142241537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case of autoimmune glial fibrillary acidic protein astrocytopathy with concurrent renal cell carcinoma 一例自身免疫性胶质纤维酸性蛋白星形细胞病变并发肾细胞癌的病例
Neuroimmunology Reports Pub Date : 2024-09-08 DOI: 10.1016/j.nerep.2024.100226
Krithika Arrabothu , Srinivas Govindan , Wilson Rodriguez , Christopher Tapia , Robert L. White III
{"title":"A case of autoimmune glial fibrillary acidic protein astrocytopathy with concurrent renal cell carcinoma","authors":"Krithika Arrabothu ,&nbsp;Srinivas Govindan ,&nbsp;Wilson Rodriguez ,&nbsp;Christopher Tapia ,&nbsp;Robert L. White III","doi":"10.1016/j.nerep.2024.100226","DOIUrl":"10.1016/j.nerep.2024.100226","url":null,"abstract":"<div><p>Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy is a novel central nervous system disorder characterized by subacute neuropsychiatric symptom development and rapid remission with corticosteroid therapy. In this paper, we describe a case of GFAP encephalitis found to have renal cell carcinoma. The patient was a 71-year-old man with a history of transient ischemic attacks, severe diabetic retinopathy and monoclonal gammopathy of undetermined significance, who presented with subacute cognitive decline. Anti-GFAP antibodies were detected in the cerebrospinal fluid. Computer Tomography (CT) of chest, abdomen and pelvis identified a renal mass that was resected. Subsequent pathology confirmed clear cell renal cell carcinoma. The patient was treated with corticosteroids with cognitive recovery near to baseline. In conclusion, we encourage the early consideration of autoimmune GFAP astrocytopathy for patients with clinical manifestation of subacute neuropsychiatric symptoms after other common conditions have been ruled out, as it usually has a great response to immunosuppressive therapy. In addition, this case highlights the importance of full body scan to identify possible underlying malignancy as a possible precipitating factor.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100226"},"PeriodicalIF":0.0,"publicationDate":"2024-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000275/pdfft?md5=2065be24e880ef5864893cd0798d0453&pid=1-s2.0-S2667257X24000275-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142241536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertrophic polyneuropathy in CMV related GBS in a paediatric patient 一名儿童患者因 CMV 引起的 GBS 而出现肥厚性多发性神经病变
Neuroimmunology Reports Pub Date : 2024-08-24 DOI: 10.1016/j.nerep.2024.100225
Bhanu B Gowda , Snehal Shah , Rahul Lakshmanan , Jonathan Silberstein
{"title":"Hypertrophic polyneuropathy in CMV related GBS in a paediatric patient","authors":"Bhanu B Gowda ,&nbsp;Snehal Shah ,&nbsp;Rahul Lakshmanan ,&nbsp;Jonathan Silberstein","doi":"10.1016/j.nerep.2024.100225","DOIUrl":"10.1016/j.nerep.2024.100225","url":null,"abstract":"","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100225"},"PeriodicalIF":0.0,"publicationDate":"2024-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000263/pdfft?md5=40986e4a76b366f1461794031233cb24&pid=1-s2.0-S2667257X24000263-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142097485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolution of optic neuritis and probable multiple sclerosis after long-term ingestion of very high doses of vitamin D3: A case report 长期摄入高剂量维生素 D3 后视神经炎和可能的多发性硬化症得到缓解:病例报告
Neuroimmunology Reports Pub Date : 2024-07-29 DOI: 10.1016/j.nerep.2024.100224
Nipith Charoenngam , Michael F. Holick
{"title":"Resolution of optic neuritis and probable multiple sclerosis after long-term ingestion of very high doses of vitamin D3: A case report","authors":"Nipith Charoenngam ,&nbsp;Michael F. Holick","doi":"10.1016/j.nerep.2024.100224","DOIUrl":"10.1016/j.nerep.2024.100224","url":null,"abstract":"<div><p>A 36-year-old male presented with 2 months of left-eye visual disturbance and was diagnosed with optic neuritis due to probable multiple sclerosis (MS). He was advised to undergo periodic ophthalmology follow-up without immunosuppressive treatment. Due to persistent symptoms, he expressed interest in very high-dose vitamin D<sub>3</sub> therapy of 54,000 IUs/day (1,000 IUs/kg/day) along with a zero-calcium diet. After starting the therapy, he experienced sustained symptomatic improvement of visual symptoms over 4 years, along with radiological stability of the optic neuritis lesion without developing hypercalcemia. This case supports the potential therapeutic efficacy of very high-dose vitamin D for MS.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"6 ","pages":"Article 100224"},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000251/pdfft?md5=7b1df6ff327984b259e7f1d7ec65313f&pid=1-s2.0-S2667257X24000251-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141952470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信